HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2258145Generated: November 1, 2026
HCID 22915344, compound → HCID 22915337, compound
https://huagongshe.com/reaction/2258145
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 22915344 | HCID 22915344 | — |
| Reactant | HCID 22915349 | HCID 22915349 | — |
| Product | HCID 22915337 | HCID 22915337 | — |
Reaction Steps
As shown in FIG. 24, the synthesis pathway for the compounds of the present invention involves starting with the following compound, Compound 1: ##STR5## This starting compound in the synthesis of Compound 2 is 4,5'-dimethyl-8-methoxypsoralen. The synthesis of this precursor compound has been described previously in the literature. See Bender, et al., J. Org. Chem. 44:2176 (1979). Alternatively, the starting compound may be synthesized by the following method: 8-acetyl-7-(2-chloroallyl)oxy-4-methylcoumarin, described in Bender, et al, J. Org. Chem. 48:2709 (1983), is initially oxidized to a phenolic compound, 7-(2-chloro-2-propenyl)oxy-8-hydroxy-4-methylcoumarin, and then methylated, providing 7-(2-chloro-2-propenyl)oxy-8-methoxy-4-methylcoumarin. Claisen rearrangement provides 6-(2-chloro-2-propenyl)-7-hydroxy-8-methoxy-4-methylcoumarin, which is then converted to 4,5'-dimethyl-8-methoxypsoralen.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05659050 |
|---|
| Source dataset | uspto-grants-1997_08 |
|---|
| ORD ID | ord-56c3cf93a19a474ea298b262ca4e7c4b |
|---|
| Source note | uspto-grants-1997_08 |
|---|